6 hrs ago | Seeking Alpha
The Joy Of Falling Stock Prices For Income Investors
One of the most beautiful, and often underappreciated, circumstances for long-term investors occurs when the prices of high-quality companies fall while the earnings and dividends of each share grow.
The following video is part of our "Motley Fool Conversations" series, in which health care editor/analyst David Williamson discusses topics across the investing world.
Johnson & Johnson seeks approval of diabetes pill
Johnson & Johnson said Thursday it filed for marketing approval to the Food and Drug Administration of its drug canagliflozin, a once-per-day pill intended to treat Type 2 diabetes.
The Cape Fear Farmers Market features local farmer-grown, local farmer-sold products.
Johnson & Johnson's McNeil unit receives criticism from FDA on quality control procedures
The Food and Drug Administration, in a May 22 letter, criticized McNeil Consumer Products for violating regulations on quality control procedures.
Janssen and Johnson & Johnson to Provide Webcast Presentation of ZYTIGA
Results from pre-specified interim analyses of COU-AA-302, a randomized, phase 3 study of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer, will be shown for the first time at ASCO.
4 Pharmaceuticals To Buy Now For Profits In 2013
Ranked among some of the largest businesses across the globe, Johnson & Johnson caters to a global market, manufacturing and selling medical and pharmaceutical products.
Five Stocks Hedge Funds are Betting Against
Goldman Sachs released a report highlighting the companies with the largest short positions among hedge funds.
3 Reasons To Buy Johnson & Johnson
Johnson & Johnson shares have pulled back with the markets and now can be bought near the 52-week lows.
The following video is part of our "Motley Fool Conversations" series, in which health-care editor/analyst David Williamson discusses topics across the investing world.
Elan Pharmaceuticals Hoping Alzheimer's Drug Will "Transform" Firm
Pharmaceuticals giant Elan could have a "path to market" for a new drug that would "transform" the company by the end of this year, the company said yesterday.
Abbott: Don't Miss Out On Its High Growth
The pharmaceuticals industry is just like the food and beverage industry in terms of sensitivity.
Betty DeGeneres Backs Johnson & Johnson, Walgreens Anti-Gay Bullying Campaign
Betty DeGeneres, Ellen DeGeneres' mom, is featured in a video promoting a campaign in support of Parents, Families & Friends of Lesbians and Gays anti-bullying efforts.
Johnson and Johnson the target of $300-million lawsuit
Diego Solimano, the lawyer for plaintiff Karen Dyler, says two groups of women - elderly women and woman who have given birth to children - are most affected by incontinence.
Johnson & Johnson: An Uncommon Opportunity
Johnson & Johnson , one of the world's leaders in the pharmaceutical, medical devices, and general consumer products industries, is a supreme opportunity for long-term value investors.
North Jersey 5th most expensive on corporate headquarters cost ranking
Johnson and Johnson headquarters in New Brunswick, which is cheaper than the northern New Jersey area for corporate headquarters, but still among the more expensive locations nationally.
Johnson & Johnson: Great Investment But Not For A Short-Term Price Rebound
On Tuesday there were a number of articles proclaiming that Johnson & Johnson is a buy right now; that the stock is due for a rebound; and that the dividend makes for a solid income play.
See Muppets on Your Band-Aid With New AR App [VIDEO]
This will help sooth your kids' booboos: Johnson & Johnson has just introduced an augmented reality app that projects image of the Muppets on their Band-Aids. As the video above shows, the iOS-based app, co-developed by JWT , can prompt a song from Kermit the Frog, a red carpet entry by Miss Piggy or a "daring act of lunacy" from Gonzo.
Buy, Sell, or Hold: Johnson & Johnson
The following video is part of our "Motley Fool Conversations" series, in which consumer goods editor/analyst Austin Smith and senior technology analyst Eric Bleeker discuss topics across the investing world.
Ex-Dividend Stocks: Johnson & Johnson, McGraw-Hill
NEW YORK -- The following stocks go ex-dividend Thursday, meaning an investor must purchase the shares Wednesday to qualify for the next dividend payment: Johnson & Johnson "We believe JNJ's business is starting to turn the corner from many of the challenges of 2010 and expect the pipeline to deliver accelerating growth," Wells Fargo analysts wrote ... (more)